Concepedia

Claudia Karnthaler‐Benbakka

CK

Statistics

Publications

4

Citations

165

H-Index

4

Active since

2013

Affiliations

University of Vienna(Current)

Comprehensive Cancer Center Vienna

Medical University of Vienna

Claudia Karnthaler‐Benbakka is an author at University of Vienna specializing in tyrosine kinase inhibitors, pharmacology, and drug discovery.

Publications per year

2013–2018

4

Publications

4

Tumor‐Targeting of EGFR Inhibitors by Hypoxia‐Mediated Activation

Claudia Karnthaler‐Benbakka, Diana Groza, Kushtrim Kryeziu et al. · Angewandte Chemie International Edition · 2014 · 71 citations

, , +17

Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair

Kushtrim Kryeziu, Ute Jungwirth, Mir Alireza Hoda et al. · Molecular Cancer Therapeutics · 2013 · 53 citations

, , +17

Targeting a Targeted Drug: An Approach Toward Hypoxia‐Activatable Tyrosine Kinase Inhibitor Prodrugs

Claudia Karnthaler‐Benbakka, Diana Groza, Bettina Koblmüller et al. · ChemMedChem · 2016 · 28 citations

, , +15

Synthesis, Characterization and <i>in vitro</i> Studies of a Cathepsin B‐Cleavable Prodrug of the VEGFR Inhibitor Sunitinib

Claudia Karnthaler‐Benbakka, Bettina Koblmüller, Marlene Mathuber et al. · Chemistry & Biodiversity · 2018 · 13 citations · Full text

, , +15

1–4 of 4